Current and historical daily PE Ratio for Lushang Freda Pharmaceutical Co Ltd (
) from 2000 to May 29 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Lushang Freda Pharmaceutical stock (SHSE:600223) PE ratio as of May 29 2024 is 34.43.
More Details
Lushang Freda Pharmaceutical Co Ltd (SHSE:600223) PE Ratio (TTM) Chart
Lushang Freda Pharmaceutical Co Ltd (SHSE:600223) PE Ratio (TTM) Historical Data
View and export this data going back to 2000. Start your Free Trial
Total 1199
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Lushang Freda Pharmaceutical PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-30 | 34.4 | 2024-03-26 | 30.7 |
| 2024-05-29 | 34.8 | 2024-03-25 | 30.7 |
| 2024-05-28 | 34.7 | 2024-03-22 | 31.6 |
| 2024-05-27 | 35.2 | 2024-03-21 | 31.8 |
| 2024-05-24 | 35.0 | 2024-03-20 | 32.1 |
| 2024-05-23 | 35.7 | 2024-03-19 | 32.3 |
| 2024-05-22 | 37.8 | 2024-03-18 | 32.2 |
| 2024-05-21 | 37.1 | 2024-03-15 | 31.4 |
| 2024-05-20 | 37.8 | 2024-03-14 | 31.4 |
| 2024-05-17 | 37.7 | 2024-03-13 | 31.3 |
| 2024-05-16 | 36.7 | 2024-03-12 | 31.7 |
| 2024-05-15 | 36.7 | 2024-03-11 | 30.9 |
| 2024-05-14 | 37.7 | 2024-03-08 | 30.8 |
| 2024-05-13 | 37.2 | 2024-03-07 | 30.3 |
| 2024-05-10 | 38.0 | 2024-03-06 | 29.7 |
| 2024-05-09 | 38.2 | 2024-03-05 | 30.1 |
| 2024-05-08 | 38.7 | 2024-03-04 | 30.4 |
| 2024-05-07 | 38.0 | 2024-03-01 | 30.1 |
| 2024-05-06 | 37.7 | 2024-02-29 | 30.4 |
| 2024-05-03 | 34.3 | 2024-02-28 | 29.2 |
| 2024-05-02 | 34.3 | 2024-02-27 | 30.1 |
| 2024-04-30 | 34.3 | 2024-02-26 | 30.0 |
| 2024-04-29 | 36.5 | 2024-02-23 | 29.3 |
| 2024-04-26 | 35.4 | 2024-02-22 | 28.4 |
| 2024-04-25 | 34.7 | 2024-02-21 | 28.2 |
| 2024-04-24 | 34.7 | 2024-02-20 | 27.0 |
| 2024-04-23 | 35.0 | 2024-02-19 | 26.7 |
| 2024-04-22 | 34.0 | 2024-02-16 | 26.5 |
| 2024-04-19 | 33.9 | 2024-02-09 | 26.5 |
| 2024-04-18 | 34.3 | 2024-02-08 | 26.5 |
| 2024-04-17 | 35.1 | 2024-02-07 | 26.7 |
| 2024-04-16 | 33.7 | 2024-02-06 | 24.5 |
| 2024-04-15 | 34.9 | 2024-02-05 | 22.3 |
| 2024-04-12 | 34.9 | 2024-02-02 | 23.9 |
| 2024-04-11 | 35.2 | 2024-02-01 | 25.4 |
| 2024-04-10 | 34.8 | 2024-01-31 | 25.1 |
| 2024-04-09 | 36.0 | 2024-01-30 | 26.0 |
| 2024-04-08 | 34.9 | 2024-01-29 | 27.3 |
| 2024-04-05 | 35.3 | 2024-01-26 | 28.5 |
| 2024-04-03 | 35.3 | 2024-01-25 | 28.4 |
| 2024-04-02 | 36.4 | 2024-01-24 | 28.1 |
| 2024-04-01 | 37.1 | 2024-01-23 | 26.9 |
| 2024-03-29 | 36.7 | 2024-01-22 | 27.2 |
| 2024-03-28 | 38.2 | 2024-01-19 | 29.8 |
| 2024-03-27 | 29.1 | 2024-01-18 | 29.7 |
Lushang Freda Pharmaceutical Co Ltd (SHSE:600223) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Lushang Freda Pharmaceutical Co Ltd
NAICS : 531190
ISIN : CNE000001147
Share Class Description:
SHSE:600223: Class ACompare
Compare
Traded in other countries / regions
600223.China IPO Date
2000-01-13Description
Lushang Freda Pharmaceutical Co Ltd formerly Lushang Health Industry Development Co Ltd is a real estate developer in China. The company is engaged in the development of office buildings, infrastructure, apartments, and hotels.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers